EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice

Hong Kyung Lee, Hwa Kyung Kim, Ji Yeon Kim iD, Ji Su Kim, JinKyung Park, Min Sung Kim, Tae Yong Lee, Key-Hwan Lim, Hanseul Park, Dong Ju Son iD, Jin Tae Hong iD, Sang-Bae Han iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hong Kyung Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungbuk National University, Chungbuk 28160, Republic of Korea. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mesenchymal Stem Cells, B-Lymphocytes, Diterpenes. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by autoantibody production by hyper-activated B cells. Although mesenchymal stem cells (MSCs) relieve lupus symptoms by inhibiting mainly T cells, whether MSCs also inhibit B cells has been controversial. Here, we found that naïve MSCs inhibited IFN-γ production by T cells, but not IgM production by B cells. We used a chemical approach to prime MSCs to inhibit B cells. We found that ingenol-3-angelate (I3A), a non-tumor-promoting phorbol ester, activated MSCs to inhibit B cells in a TGF-β1-dependent manner. We also showed that IL-1β induced MSCs to continuously secrete TGF-β1, which directly inhibited IgM production by B cells, whereas IL-1β did not. I3A-treated MSCs were better than naïve MSCs at ameliorating SLE symptoms in MRL.faslpr mice. In summary, our data provide information on how to generate MSCs that are effective for the treatment of SLE characterized by excessive B cell activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicMesenchymal Stem CellsB-LymphocytesDiterpenesAnimalsMiceMice, Inbred MRL lprFemaleTransforming Growth Factor beta1Disease Models, AnimalT-LymphocytesInterferon-gammaInterleukin-1betaImmunoglobulin MMesenchymal Stem Cell TransplantationLymphocyte Activation

Stichwörter der Autor:innen

B cellsingenol-3-angelatemesenchymal stem cellssystemic lupus erythematosus

Substanzen

Diterpenes3-ingenyl angelateTransforming Growth Factor beta1Interferon-gammaInterleukin-1betaImmunoglobulin M

Autor:innen und Institutionen

  • College of Pharmacy, Chungbuk National University, Chungbuk 28160, Republic of Korea.
  • Bioengineering Institute, CorestemChemon Inc., Gyeonggi 13486, Republic of Korea.

ORCID-Profile: Ji Yeon Kim, Dong Ju Son, Jin Tae Hong, Sang-Bae Han

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine

Zitieren

APA

Lee, H. K., Kim, H. K., Kim, J. Y., Kim, J. S., Park, J., Kim, M. S., Lee, T. Y., Lim, K. H., Park, H., Son, D. J., Hong, J. T., & Han, S. B. (2024). Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312625

Vancouver

Lee HK, Kim HK, Kim JY, Kim JS, Park J, Kim MS, et al. Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312625

BibTeX
@article{Lee2024,
  author = {Lee, Hong Kyung and Kim, Hwa Kyung and Kim, Ji Yeon and Kim, Ji Su and Park, JinKyung and Kim, Min Sung and Lee, Tae Yong and Lim, Key-Hwan and Park, Hanseul and Son, Dong Ju and Hong, Jin Tae and Han, Sang-Bae},
  title = {Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312625}
}
Kostenlos starten →